InsiderSignal.AI

InsiderSignal.ai

RXRX - Recursion Pharmaceuticals, Inc.

Insider Sale by Borgeson Blake (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Borgeson Blake, serving as Dir at Recursion Pharmaceuticals, Inc. (RXRX), sold 170,000 shares at $3.46 per share, for a total transaction value of $588,200.00. Following this transaction, Borgeson Blake now holds 6,259,863 shares of RXRX.

This sale represents a 3.00% decrease in Borgeson Blake's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 1 day after the trade was made.

Recursion Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Borgeson Blake

Dir

Blake Borgeson, Ph.D. is a Board Member and Director at Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a clinical-stage biopharmaceutical company leveraging AI and automation for drug discovery.[[3]](https://www.recursion.com/team-members/blake-borgeson)[[5]](https://www.recursion.com/team)[[2]](https://www.marketbeat.com/instant-alerts/recursion-pharmaceuticals-nasdaqrxrx-director-blake-borgeson-sells-220000-shares-2026-01-08/) He recently sold 220,000 shares of RXRX stock on January 6, 2026, at $4.36 per share, reducing his holdings to 6,649,863 shares valued at approximately $29 million.[[2]](https://www.marketbeat.com/instant-alerts/recursion-pharmaceuticals-nasdaqrxrx-director-blake-borgeson-sells-220000-shares-2026-01-08/)[[4]](https://www.tradingview.com/news/tradingview:4490a2726ccbd:0-recursion-pharmaceuticals-director-sells-220-000-shares/) Borgeson earned a bachelor's degree in electrical engineering from Rice University and conducted research in real-time navigation software for surgical procedures at the M.E.Mueller Institute in Switzerland.[[3]](https://www.recursion.com/team-members/blake-borgeson) In 2005, he co-founded BuildASign.com, an e-commerce company that grew to over 350 employees and $80 million in revenue by 2015.[[3]](https://www.recursion.com/team-members/blake-borgeson) He later transitioned to an advisory role while completing a Ph.D. in bioinformatics at UT Austin in the Marcotte Lab, focusing on machine learning for mapping protein complexes.[[3]](https://www.recursion.com/team-members/blake-borgeson)

View full insider profile →

Trade Price

$3.46

Quantity

170,000

Total Value

$588,200.00

Shares Owned

6,259,863

Trade Date

Tuesday, March 3, 2026

2 days ago

SEC Filing Date

Wednesday, March 4, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Recursion Pharmaceuticals, Inc.

Company Overview

No company information available
View news mentioning RXRX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4496953

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime